What Are the Most Common Targeted Cancer Drugs? Key Targets and Treatment Uses
What are the most common targeted cancer drugs? Common targeted cancer drugs include therapies targeting…
Articles
Innovative PNH Drug Licancopan Approved in China: Oral CFB Inhibitor for Dual Hemolysis Control
On August 20, NMPA announced the approval of Licancopan Fumarate Capsules, a Class 1 innovative…
Anflekitug Approved in China: A New IL-1β Targeted Treatment Option for Acute Gouty Arthritis
On August 20, 2026, Anflekitug was approved in China as an innovative drug developed by…
China Innovative Oncology Drugs: 15 New Approvals in H1 2026
According to publicly available information, 38 innovative drugs were approved for marketing in China in…
Felzartamab Approved for Multiple Myeloma: Another CD38 Monoclonal Antibody Enters the Chinese Market
Felzartamab is a CD38-targeting human monoclonal antibody, with Felzartamab approved for multiple myeloma in China…
Tinengotinib Approved for Cholangiocarcinoma in China, Addressing FGFR Inhibitor Resistance
Tinengotinib approved for cholangiocarcinoma marks an important advance for patients with FGFR2 fusion or rearrangement-positive…
Breast Cancer Drug List in China: Common Endocrine, Targeted, ADC, and Chemotherapy Drugs
The breast cancer drug list in China mainly includes endocrine therapy drugs, HER2-targeted drugs, CDK4/6…
How to Identify the Early Signs of Melanoma: The ABCDE Rule and Warning Signs
Key Takeaways Melanoma is a malignant tumor that originates from melanocytes and most commonly develops…
What Are the Most Common Chemotherapy Drugs? 10 Frequently Used Medications
What are the most common chemotherapy drugs? Common chemotherapy drugs include Cisplatin, Carboplatin, Oxaliplatin, Paclitaxel,…
Recibokibart Approved for GPP: China-Developed IL-36R Antibody Brings a New Treatment Option for Generalized Pustular Psoriasis
Recibokibart approved for GPP marks a major milestone in Generalized Pustular Psoriasis (GPP) treatment. Developed…